Influenza News and Research

Latest Influenza News and Research

Do not underestimate the serious impact of the H1N1 virus, say researchers

A research team has warned medical experts in the Northern Hemisphere not to underestimate the serious impact of the H1N1 (Swine flu) virus with a new report showing that many patients who were critically ill with the virus required prolonged life support treatment with heart-lung machines.

14 Oct 2009

Rapid rollout of H1N1 vaccines is effective in reducing infection rates according to simulation model

Early action, especially rapid rollout of vaccines, is extremely effective in reducing the attack rate of the H1N1 influenza virus, according to a simulation model of a pandemic outbreak reported in a new study in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.

14 Oct 2009

American Lung Association to raise awareness about the seriousness of seasonal influenza

In the spirit of "healthy competition," the American Lung Association in Minnesota is teaming up with the Minneapolis and St. Paul Fire Departments to raise awareness about the seriousness of seasonal influenza and the importance of vaccination this year.

14 Oct 2009

New Ultra Sensitive facemasks to protect against seasonal and swine flu

BIOSAFE, Inc., a company that manufactures and sells a novel antimicrobial polymer, has announced that they are launching in specific markets outside the United States through a unique facemask treated with BIOSAFE(®). Crosstex' new BIOSAFE-treated Ultra Sensitive facemasks begin to reduce microorganisms such as MRSA, VRE, and Staph immediately upon contact, and have further proven to be effective against Influenza A strains such as seasonal flu and the novel H1N1 virus.

14 Oct 2009

Studies examine H1N1 treatment, outcome differences in Mexico, Canada

New studies suggest that "[d]eveloping countries with limited access to advanced health-care facilities may be in for a rough ride with swine [H1N1] flu and even countries with high-tech ICUs may find themselves pushed to the limit as their hospitals struggle to save gravely ill H1N1 patients," the Canadian Press reports.

14 Oct 2009

NIH awards $2.2m grant to Smiths Detection to develop a test for multiple types of influenza

Smiths Detection today announces the award of a $2.2m, two-year grant from the National Institute of Allergy and Infectious Diseases, part of the US National Institutes of Health (NIH), to develop a test for multiple types of influenza.

14 Oct 2009

Study says critical illness among Canadian patients with H1N1 occurred rapidly after hospital admission

Critical illness among Canadian patients with 2009 influenza A(H1N1) occurred rapidly after hospital admission, often in young adults, and was associated with severely low levels of oxygen in the blood, multi-system organ failure, a need for prolonged mechanical ventilation, and frequent use of rescue therapies, according to a study to appear in the November 4 issue of JAMA.

13 Oct 2009

Johnson & Johnson announces financial results for the third quarter of 2009

Johnson & Johnson today announced sales of $15.1 billion for the third quarter of 2009, a decrease of 5.3% as compared to the third quarter of 2008. Operational results declined 2.8% and the negative impact of currency was 2.5%. Domestic sales declined 8.1%, while international sales declined 2.5%, reflecting operational growth of 2.4% and a negative currency impact of 4.9%.

13 Oct 2009

Massive mismanagement leads to catastrophic decline in freshwater biodiversity

The world will miss its agreed target to stem biodiversity loss by next year, according to experts convening in Cape Town for a landmark conference devoted to biodiversity science.

13 Oct 2009

Psoriasis patients taking immunosuppressive drugs at increased risk of H1N1 flu viruses

People with psoriasis and/or psoriatic arthritis who are taking biologic or non-biologic immunosuppressive medications should receive the inactived forms of both seasonal influenza and H1N1 (swine flu) vaccines as soon as possible, according to a recommendation from the National Psoriasis Foundation.

13 Oct 2009

Health care workers raise troubling concern about H1N1 and seasonal flu vaccines

Hospital workers are asking the same questions about the safety and necessity of flu vaccines as the general public, according to a survey conducted by the American Society of Health-System Pharmacists (ASHP).

13 Oct 2009

Cox's initiative to safeguard the community at-large

Recognized as a leader in serving its customers with state-of-the-art cable, broadband and entertainment services, Cox will soon broaden its local impact by safeguarding the community at-large. On October 30, 2009, Cox will be the first and only private corporation to operate as one of three Orange County locations to conduct an Orange County Health Care Agency (OCHCA) Point-Of-Dispensing (POD) at its Rancho Santa Margarita headquarters.

13 Oct 2009

Fully-insured members of Guardian to receive 100% coverage of the administrative cost of H1N1 vaccine

The Guardian Life Insurance Company of America (Guardian), one of the largest mutual life insurers and a leading provider of employee benefits for small and mid-sized companies, today announced that it will cover 100% of the cost associated with the administration of the H1N1 vaccine for employees and their eligible dependents enrolled in a fully-insured Guardian medical plan.

13 Oct 2009

Educational video on seasonal and H1N1 vaccines development

Will a four-minute educational video about a team of Air Force researchers investigating the H1N1 influenza virus go "viral" with middle- and high-school students?

12 Oct 2009

Fully insured members of AvMed Health to receive coverage for H1N1 flu administration fees

AvMed Health Plans announced that it will cover H1N1 flu administration fees for all of its fully insured members. Co-pays, co-insurance and deductibles will not apply for administration of the H1N1 vaccine even if they have a benefit plan that does not include immunizations.

12 Oct 2009

H1N1 illness in young Mexican patients associated with severe acute respiratory distress syndrome

Critical illness from 2009 influenza A(H1N1) in Mexico occurred among young patients, was associated with severe acute respiratory distress syndrome and shock, and had a fatality rate of about 40 percent, according to a study to appear in the November 4 issue of JAMA.

12 Oct 2009

ImmuneRegen BioSciences to test efficacy of Homspera against H5N1 Avian Influenza

ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR Biosciences Holdings, Inc. (OTCBB: IRBS), today announced that its lead anti-influenza drug, Homspera, will be tested for efficacy against highly lethal H5N1 Avian Influenza in the laboratories of a widely respected University scientist. Additionally, testing at an independent facility will further define the adjuvant efficacy of Homspera when coupled with a novel vaccine for H5N1 in studies sponsored by an ImmuneRegen industry partner.

12 Oct 2009

Public forum and scientific workshop on women's health issues

The Northwestern University Feinberg School of Medicine and Northwestern Memorial Hospital will host a public forum and scientific workshop Oct. 14 to 16 to discuss emerging issues of importance for the National Institutes of Health (NIH) for women's health research in the coming decade.

12 Oct 2009

NIH to launch 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women, children and youth

The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in pregnant women launched yesterday, and a trial to conduct the same test in HIV-infected children and youth will begin next week.

12 Oct 2009

Presentations on efficacy of interferon to combat influenza

Amarillo Biosciences, Inc. (ABI) today announced that Professor Dr. Otto Haller from the Department of Virology, Freiburg University, Germany and Professor Dr. Oliver Planz from the Friedrich Loeffler Institute, Tubingen, Germany gave two separate presentations on the efficacy of interferon to combat influenza.

12 Oct 2009

Influenza News and Research

Latest Influenza News and Research

Do not underestimate the serious impact of the H1N1 virus, say researchers

Rapid rollout of H1N1 vaccines is effective in reducing infection rates according to simulation model

American Lung Association to raise awareness about the seriousness of seasonal influenza

New Ultra Sensitive facemasks to protect against seasonal and swine flu

Studies examine H1N1 treatment, outcome differences in Mexico, Canada

NIH awards $2.2m grant to Smiths Detection to develop a test for multiple types of influenza

Study says critical illness among Canadian patients with H1N1 occurred rapidly after hospital admission

Johnson & Johnson announces financial results for the third quarter of 2009

Massive mismanagement leads to catastrophic decline in freshwater biodiversity

Psoriasis patients taking immunosuppressive drugs at increased risk of H1N1 flu viruses

Health care workers raise troubling concern about H1N1 and seasonal flu vaccines

Cox's initiative to safeguard the community at-large

Fully-insured members of Guardian to receive 100% coverage of the administrative cost of H1N1 vaccine

Educational video on seasonal and H1N1 vaccines development

Fully insured members of AvMed Health to receive coverage for H1N1 flu administration fees

H1N1 illness in young Mexican patients associated with severe acute respiratory distress syndrome

ImmuneRegen BioSciences to test efficacy of Homspera against H5N1 Avian Influenza

Public forum and scientific workshop on women's health issues

NIH to launch 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women, children and youth

Presentations on efficacy of interferon to combat influenza

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Influenza News and Research

Latest Influenza News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in